Bal Pharma Ltd. - Research Center
524824 BALPHARMA Group (B) BSE data
Add to watchlist
| Results |
Annual
|
| Statement | |
| More |
Annual results in brief
(Rs crore)
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Sales | 303.10 | 280.37 | 249.31 | 170.67 | 223.08 |
| Operating profit | 26.03 | 23.20 | 26.32 | 6.26 | 20.30 |
| Interest | 12.16 | 10.40 | 11.96 | 12.42 | 12.71 |
| Gross profit | 16.03 | 19.29 | 17.06 | -2.54 | 10.31 |
| EPS (Rs) | 3.90 | 5.78 | 6.14 | -6.72 | 4.62 |
Annual
results in details
| Mar ' 23 | Mar ' 22 | Mar ' 21 | Mar ' 20 | Mar ' 19 | |
|---|---|---|---|---|---|
| Other income | 2.15 | 6.49 | 2.70 | 3.62 | 2.72 |
| Stock adjustment | -17.90 | -4.85 | 5.13 | -3.43 | -4.41 |
| Raw material | 176.45 | 162.95 | 135.47 | 79.44 | 113.64 |
| Power and fuel | - | - | - | - | - |
| Employee expenses | 51.91 | 44.46 | 39.62 | 48.77 | 48.67 |
| Excise | - | - | - | - | - |
| Admin and selling expenses | - | - | - | - | - |
| Research and development expenses | - | - | - | - | - |
| Expenses capitalised | - | - | - | - | - |
| Other expenses | 66.61 | 54.61 | 42.77 | 39.64 | 44.88 |
| Provisions made | - | - | - | - | - |
| Depreciation | 7.48 | 7.24 | 7.26 | 7.03 | 6.12 |
| Taxation | 2.42 | 3.48 | 0.70 | -0.04 | -2.35 |
| Net profit / loss | 6.12 | 8.57 | 9.10 | -9.53 | 6.55 |
| Extra ordinary item | - | -0.01 | - | - | - |
| Prior year adjustments | - | - | - | - | - |
| Equity capital | 15.69 | 14.82 | 14.82 | 14.17 | 14.17 |
| Equity dividend rate | - | - | - | - | - |
| Agg.of non-prom. shares (Lacs) | - | - | - | - | - |
| Agg.of non promotoholding (%) | - | - | - | - | - |
| OPM (%) | 8.59 | 8.28 | 10.56 | 3.67 | 9.10 |
| GPM (%) | 5.25 | 6.73 | 6.77 | -1.46 | 4.57 |
| NPM (%) | 2.01 | 2.99 | 3.61 | -5.47 | 2.90 |
© 2024 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback
DISCLAIMER: All financials are on standalone basis